JOANNA BEITZEL: Open Payments
NPI 1417638065 · BEL AIR, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,810 in 58 payments from 13 companies in 2025. Trend: 2023 $104 · 2024 $660 · 2025 $1,810
Food & beverage: $1,810
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 10 | $649 |
| ABBVIE INC. | 15 | $372 |
| Madrigal Pharmaceuticals | 9 | $162 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $144 |
| Janssen Scientific Affairs, LLC | 2 | $135 |
| Gilead Sciences, Inc. | 3 | $69 |
| Phathom Pharmaceuticals, Inc. | 3 | $58 |
| Lilly USA, LLC | 2 | $57 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $55 |
| Aimmune Therapeutics, Inc. | 1 | $35 |
Products named: TREMFYA, REZDIFFRA, CREON, SKYRIZI, ENTYVIO, LINZESS, RINVOQ, VOQUEZNA.
Industry payments across MD — which companies pay providers there.
